Speaker illustration

Doctor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

Member of:

Heart Failure Association

Updated meta-analysis of biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent implantations

Event: ESC CONGRESS 2019

Topic: Revascularisation

Session: Optimal treatment of coronary artery disease

Thumbnail

The effect of initial pulse pressure on heart failure readmission in hypertensive octogenarian patients presenting acute myocardial infarction treated with percutaneous coronary intervention

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Hypertension, Other

Session: Hypertension

Thumbnail

Sexual differences in heart failure with mid-range ejection fraction patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

The effect of ejection fraction change during follow-up on outcomes in patients with heart failure with mid-range ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Prognosis of biodegradable polymer drug-eluting stents versus second-generation durable polymer drug-eluting stents in acute myocardial infarction patients following percutaneous coronary intervention

Event: ESC Congress 2018

Topic: Stents

Session: Outcome of coronary stenting up to 10 years

Thumbnail

The impact of coronary artery disease on clinical outcomes in heart failure with mid-range ejection fraction patients

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Comparison of Prescription and Bleeding Rates and Clinical Outcomes of Contemporary P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Event: ESC CONGRESS 2017

Topic: Adjunctive medical therapy

Session: Best Posters in antiplatelet agents in acute coronary syndromes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk